Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes - Report - MDSpire

Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes

  • By

  • Krzysztof Bereza

  • Andrzej Kukiełka

  • Dominika Trojnarska

  • Beniamin Oskar Grabarek

  • Marcin Opławski

  • Tomasz Banaś

  • July 2, 2026

  • 0 min

Share

Clinical Report: Evaluation of Urinary Function in Women Post-Cervical Cancer Treatment

Overview

This multicenter study assessed urinary function and quality of life in 132 women treated for cervical cancer.

Background

Cervical cancer treatment can lead to long-term urinary dysfunction and negatively impact quality of life. Understanding these outcomes is crucial.

Data Highlights

GroupPatientsUrinary Dysfunction
Surgery Alone15Increased
Surgery + Adjuvant Therapy53Increased
Radiotherapy26Increased
Control Group38Normal

Key Findings

  • Urinary dysfunction increased over time, especially in patients receiving radiotherapy.
  • Normal bladder function decreased, while overactive bladder and mixed urinary incontinence increased.
  • Urodynamic findings showed reduced bladder capacity and increased post-void residual volume in radiotherapy patients.
  • Life satisfaction and sexual function deteriorated post-treatment, particularly in those receiving combined therapies.
  • Weak correlations existed between urodynamic findings and patient-reported outcomes.

Clinical Implications

Healthcare providers should be aware of the potential for persistent urinary dysfunction and quality of life deterioration in cervical cancer survivors, particularly those treated with radiotherapy. Comprehensive evaluations combining urodynamic assessments and patient-reported outcomes may aid in identifying patients in need of supportive care.

Conclusion

Cervical cancer treatment, especially radiotherapy, is associated with significant long-term urinary dysfunction and quality of life challenges. Integrating objective and subjective assessments can enhance understanding and management of these issues.

Related Resources & Content

  1. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
  2. Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263)
  3. World Journal of Urology — Recurrent UTI quality of life questionnaire: pilot study evaluating the impact of recurrent urinary tract infection on quality of life in postmenopausal women
  4. Assessing the Effects of Urogenital Organ Displacement Following Abdominoperineal Resection on Urinary and Sexual Function
  5. Effects of Transurethral Resection of Bladder Tumors on Sexual Health and Quality of Life Assessed via ePROMs in Bladder Cancer Patients: A Prospective Cohort Analysis
  6. Comparative Analysis of Urogenital Outcomes in Robotic versus Laparoscopic Approaches for Rectal Cancer Surgery
  7. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023* - PMC
  8. Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263) - PMC
  9. International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure‐flow study

Original Source(s)

Related Content